TGFB1 and neoplasm: Our group has also developed oncolytic adenoviruses expressing soluble TGF-β receptor II fusion human IgG Fc fragment (sTGFβRIIFc), which can block TGF-β signaling and inhibit tumor bone metastasis [23,24].